uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

QURE uniQure NV

Pre-Mkt 05-27 06:34:30 EDT

25.15

+0.96

+3.97%

盘前25.18

+0.03+0.12%

05:11 EDT

High25.52	Low24.00	Vol1.22M
Open24.41	D1 Closing24.19	Amplitude6.28%
Mkt Cap1.59B	Tradable Cap1.25B	Total Shares63.03M
T/O30.53M	T/O Rate2.46%	Tradable Shares49.72M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"QURE","market":"US","secType":"STK","nameCN":"uniQure NV","latestPrice":25.15,"timestamp":1779825600000,"preClose":24.19,"halted":0,"volume":1222292,"hourTrading":{"tag":"盘前","latestPrice":25.18,"preClose":25.15,"latestTime":"05:11 EDT","volume":256,"amount":6423.389184,"timestamp":1779873116277,"change":0.03,"changeRate":0.001193,"amplitude":0.027038},"delay":0,"changeRate":0.03968582058701932,"floatShares":49724600,"shares":63033249,"eps":-3.486371,"marketStatus":"Pre-Mkt","change":0.96,"latestTime":"05-27 06:34:30 EDT","open":24.41,"high":25.52,"low":24,"amount":30534789.048236,"amplitude":0.062836,"askPrice":25.19,"askSize":227,"bidPrice":22.41,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.486371,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779888600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1391576400000,"exchange":"NASDAQ","adjPreClose":25.15,"preHourTrading":{"tag":"盘前","latestPrice":25.18,"preClose":25.15,"latestTime":"05:11 EDT","volume":256,"amount":6423.389184,"timestamp":1779873116277,"change":0.03,"changeRate":0.001193,"amplitude":0.027038},"postHourTrading":{"tag":"盘后","latestPrice":25,"preClose":25.15,"latestTime":"19:07 EDT","volume":336123,"amount":8453285.639,"timestamp":1779836851225,"change":-0.15,"changeRate":-0.005964,"amplitude":0.018091},"volumeRatio":1.1392190244040774,"impliedVol":1.3342,"impliedVolPercentile":0.62},"requestUrl":"/m/hq/s/QURE/wiki","defaultTab":"wiki","newsList":[{"id":"2638755899","title":"A Look At uniQure (QURE) Valuation After AMT-130 Gene Therapy Regulatory Plans And Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2638755899","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638755899?lang=en_us&edition=fundamental","pubTime":"2026-05-25 20:13","pubTimestamp":1779711235,"startTime":"0","endTime":"0","summary":"uniQure (QURE) drew fresh investor focus after announcing plans to seek UK regulatory approval for its AMT-130 gene therapy, supported by Phase 1/2 data indicating a 75% slowing of Huntington’s disease progression at a high dose.\nSee our latest analysis for uniQure.\nThe stock has pulled back slightly in the last week, with a 7 day share price return of a 2.97% decline. However, the 30 day share price return of 34.17% and 1 year total shareholder return of 59.56% point to solid underlying...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/a-look-at-uniqure-qure-valuation-after-amt-130-gene-therapy","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/a-look-at-uniqure-qure-valuation-after-amt-130-gene-therapy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","BK4588","LU0109394709.USD","QURE","BK4219","BK4084","BK4585","AMT","BK4534","BK4139","BK4554","LU0320765992.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636810921","title":"Biotech Investors Are Tuning Out the MAHA Chaos -- Heard on the Street -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2636810921","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636810921?lang=en_us&edition=fundamental","pubTime":"2026-05-20 17:30","pubTimestamp":1779269400,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration is rudderless. Its commissioner, Marty Makary, is gone. Much of the agency's senior leadership has been purged, and the scientific ranks have been hollowed out.For the agency, the damage done could take years to repair. But for investors, risk is actually fading.The rise of the Make America Healthy Again movement, with its vaccine skepticism and adversarial stance toward drugmakers, has hung over biotech since Robert F. Kennedy Jr. took over at the Department of Health and Human Services.Kennedy is still atop HHS, and MAHA still has sway over parts of the American public. But for Wall Street, the political risk of investing in drug companies has been demoted: It now sits well below interest rates, clinical data and earnings in the hierarchy of concerns.The XBI's performance under Trump tells the story. The ETF plunged after Trump's election win in November 2024, declining about 30% by April 2025. It then began a sharp recovery, as Makary","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU2468319806.SGD","IE0002141913.USD","BK4581","LU1989763427.SGD","BK4533","IE00BJT1NW94.SGD","SG9999002232.USD","BK4588","LU1061106388.HKD","LU2324357040.USD","BK4504","LU1721429741.USD","BK4585","BK4211","LU0114720955.EUR","MRNA","QURE","XBI","IE00BJJMRZ35.SGD","ABT","LU0234572021.USD","REPL","SGXZ41872573.SGD","BK4568","MRNX","LU0122379950.USD","LU0170899867.USD","LU2089984988.USD","MRNY","LU1989763690.USD","LU1914381329.SGD","BK4566","IE00B4R5TH58.HKD","SG9999002224.SGD","LU0289739699.SGD","LU1691799644.USD","LU2237957902.USD","SGXZ23171101.USD","LU0889565916.HKD","LABU","BK4532","LU0109394709.USD","BK4082","ISBC","BK4551","LU2133065610.SGD","BK4548","LU1057294990.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635734151","title":"Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2635734151","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635734151?lang=en_us&edition=fundamental","pubTime":"2026-05-14 01:34","pubTimestamp":1778693655,"startTime":"0","endTime":"0","summary":"Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum loomsBy Christy Santhosh May 13 (Reuters) - U.S. Food and Drug Administration Commissioner Dr. Marty Makary's departure com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL4N41Q12I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4533","BK4532","REPL","BK4568","QURE","BK4588","BK4501","BK4548","BK4139","MRNA","BK4551","BK4585","MRNX","BK4534","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635877657","title":"BUZZ-U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2635877657","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635877657?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:08","pubTimestamp":1778677729,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio HoldingsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call n","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL6N41Q0SN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423091.SGD","LU0553294199.USD","HK0000286598.CNH","LU1688375341.USD","SGXZ90724238.SGD","BK4599","LU0320764243.SGD","LU1169590202.USD","LU0054237671.USD","LU0545039389.USD","LU0823040885.USD","LU0210536198.USD","LU1894683348.USD","BK4105","LU2097828474.EUR","IE0034224299.USD","LU0516422440.USD","LU1961090484.USD","BABO","LU1568876251.USD","LU1674673691.USD","LU2456880835.USD","LU1044876610.USD","LU0543330483.HKD","LU2097829019.USD","LU0163747925.USD","IE00BBT3K403.USD","LU1366334578.USD","DT","LU0463099449.HKD","NBIS","LU0229945570.USD","LU0164865239.USD","LU2125910500.SGD","IE00B7SZL793.SGD","IE000M9KFDE8.USD","IE0002141913.USD","KBAB","LU0128522744.USD","LU2087589342.USD","BK1588","LU2357305700.SGD","SG9999001440.SGD","IE0002270589.USD","LU0348783662.USD","LU0868486357.SGD","LU0531971595.HKD","LU0630378692.HKD","LU1044875133.USD","LU1983299246.USD","LU1861215975.USD","SG9999001093.SGD","LU0588546209.SGD","LU1366334651.USD","LU0516423174.USD","LU0501845795.SGD","IE00BDGV0183.EUR","BK1608","IE00B29SXL02.USD","LU0426412945.USD","LU0823041008.USD","SG9999002562.SGD","LU0572944931.SGD","BK4116","LU0210527791.USD","REI","LU2471134879.HKD","LU0261950983.USD","LU2505996509.AUD","LU0234572021.USD","IE00B894F039.SGD","LU1981816686.USD","LU2488822045.USD","LU0426417589.USD","LU0047713382.USD","LU0345776255.USD","LU0210528500.USD","LU1328277881.USD","SG9999002232.USD","IE0009355771.USD","BK4614","BK4502","LU0259732245.USD","BK4609","SG9999002828.SGD","SG9999011175.SGD","LU1032466523.USD","LU2430703095.HKD","LU0456842615.SGD","LU1242518857.USD","LU0577902371.SGD","BK4196","LU2403377893.USD","IE00B3PB1722.GBP","LU0251144936.SGD","BK4534","IE00B19Z4B17.USD","LU0306807586.USD","LU0784639295.USD","LU1152091168.USD","LU2125910849.SGD","IE00BSNM7G36.USD","LU2039709279.SGD","BABX","LU2430703251.USD","LU0345775950.USD","BK4504","LU1629891620.HKD","LU1674673428.USD","BK4606","SG9999000327.SGD","BK4535","IE00B29SXK94.USD","LU0315178854.USD","LU0577902611.USD","LU0795875086.SGD","SGXZ62798434.SGD","IE00BN8TJ469.HKD","LU2756315318.SGD","IE000F7OJYX1.SGD","LU1642822792.SGD","LU0348783233.USD","LU0516422952.EUR","LU0985320562.USD","LU1201861165.SGD","LU0235996351.USD","LU0244354667.USD","BK4607","LU2129689431.USD","IE0032431581.USD","BK4524","LU0441854154.USD","SG9999001903.USD","VELO","LU0880133367.SGD","LU1880383440.USD","LU0084288322.USD","BK4581","LU0661504455.SGD","LU1105468828.SGD","LU0149534421.HKD","LU1496350502.SGD","BK4187","LU0348816934.USD","IE000MB6IJN5.SGD","LU1548497426.USD","SG9999001176.SGD","LU1046421795.USD","LU0541501648.USD","LU0321505439.SGD","LU0469268626.HKD","LU0203345920.USD","LU0488056044.USD","LU0650527681.SGD","LU0757428866.USD","BK1586","LU0889566641.SGD","BK4603","LU1196710864.SGD","HBBD.SI","LU0898667661.SGD","LU1720050803.USD","LU2129689605.HKD","LU1960683339.HKD","LU1035773651.USD","AEIS","LU0310800965.SGD","LU0326950275.SGD","LU0634319403.HKD","LU1935042991.SGD","LU2129689514.USD","LU1807302812.USD","BK4170","LU1044874839.SGD","LU1778281490.HKD","LU0444973449.USD","LU0531971165.HKD","LU1815336091.USD","BK1501","LU0006061336.USD","LU0708995153.HKD","LU0314106906.USD","BK4538","SG9999001176.USD","LU0048580855.USD","LU0823413660.USD","LU1023059063.AUD","LU0630378429.USD","LU0359202008.SGD","EOSE","LU2471134796.USD","LU1551013425.SGD","LU1914381329.SGD","LU2294711713.HKD","BK4141","LU0819121731.USD","LU0979878070.USD","LU0225284248.USD","LU0689626769.HKD","LU0873338254.USD","LU0791590937.USD","IE00B66KJ199.SGD","LU1224444064.USD","LU1224709979.USD","LU0130103400.USD","BK4527","LU0608807946.USD","LU1115378108.SGD","LU0052756011.USD","LU0170899867.USD","LU0214875030.USD","LU1880398554.USD","LU0293314216.USD","IE00B0169N27.USD","LU0787776722.HKD","LU1162221912.USD","LU1244550577.SGD","LU2226246903.HKD","09988","LU0289739699.SGD","LU0456855351.SGD","BK4588","LU0683600562.USD","LU1815336760.USD","LU1929549753.HKD","LU0127658192.USD","LU0321505868.SGD","IE00B19Z3581.USD","LU1823568750.SGD","LU0348788117.USD","LU1211504680.USD","IE000WAW04H5.SGD","LU1093756325.SGD","LU1244550494.USD","BK4007","LU0328353924.USD","BK1615","LU0320764755.SGD","LU0029874905.USD","LU0640476718.USD","BK4592","BK1575","BK4550","IE0001KFT4U8.USD","LU0449509016.USD","LU0700851271.USD","LU0594300179.USD","SG9999004220.SGD","LU0117844026.USD","LU0737861699.HKD","LU1831875114.USD","HK0000320223.HKD","IE00B3T34201.USD","LU0531970944.HKD","LU1228905540.USD","BK4096","IE00BFXG1179.USD","BK4519","LU0114720955.EUR","BK1249","IE00BVYPNV92.GBP","LU2602419157.SGD","SG9999014674.SGD","IE00BFMHRM44.USD","LU1732800096.USD","LU0456846285.SGD","LU0456827905.SGD","LU0862451837.USD","LU1852331112.SGD","IE00BZ08YS42.EUR","WOLF","LU0067412154.USD","LU1074936037.SGD","BK4146","LU0128522157.USD","LU1720051108.HKD","LU2152927971.USD","LU0140636845.USD","LU0762542818.HKD","IE00B7SZLL34.SGD","LU0039217434.USD","LU0985481810.HKD","JNJ","LU1282651048.USD","LU1316542783.SGD","LU1303224171.USD","LU2236285917.USD","LU0329931090.USD","BBYY","LU0994945656.USD","LU1066053197.SGD","BK4213","LU2133065610.SGD","LU1251922891.USD","LU0577902454.USD","LU0823414551.USD","LU0061477393.USD","LU0572940350.SGD","LU0225771236.USD","LU0577902298.EUR","LU0541502299.USD","LU2476274308.USD","LU0359201612.USD","GB00BDT5M118.USD","RCAX","LU0912757837.SGD","LU0173614495.USD","LU0605514214.HKD","LU2045819591.USD","WDC","IE00B543WZ88.USD","IE00B0JY6N72.USD","LU1861220033.SGD","LU0043850808.USD","LU0164880469.USD","BK4081","LU0320765992.SGD","LU1670628061.USD","MDGL","LU1323998911.USD","HK0000306685.HKD","WIX","LU0588545904.SGD","LU1169589451.USD","LU2257852520.SGD","LU2756315664.SGD","LU2592432038.USD","LU0708995583.HKD","LU0651946864.USD","LU1023057109.AUD","IE00BMPRXN33.USD","LU0432979614.USD","BK4568","SG9999001226.SGD","BK4560","HK0000151867.HKD","LU1993786604.SGD","LU0963586101.USD","LU0823414478.USD","LU1328615791.USD","LU0831093199.SGD","SG9999000459.SGD","LU0054450605.USD","LU0577902538.SGD","LU0792757196.USD","LU1515016050.SGD","LU2112291526.USD","BABW","BK1142","LU0197773673.USD","LU0611395673.USD","LU1066051225.USD","LU0345769128.USD","LU0449515922.USD","LU0540923850.HKD","IE00BJT1NW94.SGD","LU2148611432.USD","LU2468319806.SGD","LU1228905037.USD","LU0106959298.USD","LU1813983027.USD","LU1282651121.HKD","LU0689472784.USD","LU0251143458.SGD","BK4565","LU2417539215.USD","LU0918141887.USD","LU1145028129.USD","QURE","LU0098860793.USD","LU1894683264.USD","LU0964807845.USD","LU0320764599.SGD","LU1868837565.USD","LU0124676726.USD","LU0889565916.HKD","LU1504937902.USD","WDCX","IE0000B7K699.USD","LU2778985437.USD","IE0003895053.USD","BK4554","LU0052750758.USD","LU0823413587.USD","LU1883839398.USD","LU1880398471.USD","LU1261432733.SGD","LU0865486749.SGD","LU1769817179.HKD","LU1770034418.SGD","NBIG","LU0264606111.USD","LU0648948544.HKD","LU0314109678.HKD","LU1282648689.USD","LU2347655156.SGD","LU0096374516.USD","LU1188198961.HKD","LU0543330566.HKD","LU1956131251.USD","LU0455707207.USD","LU2471134523.USD","LU0417516571.SGD","LU1720051017.SGD","LU2399975544.HKD","LU2750360997.AUD","LU1267930227.SGD","LU2249611893.SGD","LU2471134952.CNY","BK1502","LU1048588211.SGD","LU0345769631.USD","LU1048484197.HKD","IE00BVYPNW00.USD","LU1280957306.USD","ALBmain","SG9999002463.SGD","BK4505","LU0210526637.USD","LU0261947096.USD","LU0588545490.SGD","LU0820561818.USD","LU0348814723.USD","LU0048388663.USD","LU0672654166.SGD","LU0231483743.USD","LU1069347547.HKD","LU0348825331.USD","SG9999002224.SGD","SNXX","BK4077","LU0943347566.SGD","LU1235294995.USD","IE00B42XCP33.USD","LU0234570918.USD","AEP","LU0516422366.SGD","LU1048596156.SGD","LU2294711473.HKD","LU0228367735.SGD","LU0499858602.USD","LU0791591158.USD","LU0823038988.USD","SGXZ57979304.SGD","IE00BPRC5H50.USD","LU0871576103.HKD","LU0348735423.USD","IE00B19Z9P08.USD","LU0823431647.USD","IE00BFTCPJ56.SGD","LU0828237510.HKD","LU0431992006.USD","LU2896262040.SGD","LU0762541174.USD","LU0886674414.USD","LU3063872942.SGD","89988","LU1655091459.SGD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU0165289439.USD","BABA","LU0329678170.USD","LU0320765646.SGD","IE00B1BXHZ80.USD","IE00BZ08YR35.GBP","LU0197773160.USD","IE00BGHQF631.EUR","LU0651947912.USD","LU0130518102.USD","LU0327786744.USD","SG9999006597.SGD","LU1196500208.SGD","LU1059921491.USD","LU0329931173.USD","LU1008478684.HKD","LU1585245621.USD","LU0882574055.USD","BK1618","LU0012050646.USD","LU0106252389.USD","BK1517","SG9999013999.USD","LU0828237940.HKD","LU0081259029.USD","BK4558","LU0370786039.SGD","BK4532","LU0287142896.SGD","LU0957808578.USD","LU1481107354.HKD","LU1093756168.USD","LU1551013342.USD","PSNL","IE000SO60NU8.SGD","BK4220","LU0058720904.USD","BIRK","LU0950373646.USD","SG9999006514.SGD","LU0823426308.USD","IE00B2B36J28.USD","LU1670627923.USD","LU0868494617.USD","LU2506951792.HKD","LU0011963245.USD","SG9999001689.USD","LU0029875118.USD","LU2089984988.USD","LU0648000940.SGD","LU0164872284.USD","BK4548","IE00B19Z9Z06.USD","LU0122379950.USD","LU0607220059.USD","LU0132412106.USD","BK4097","LU1868838027.USD","LU0642271901.SGD","IE00BMPRXR70.SGD","LU1061106388.HKD","HK0000306701.USD","LU1878469433.USD","LU0762540952.USD","NBIZ","LU0196878994.USD","LU0051755006.USD","BK4531","LU0315179316.USD","BK4157","LU0918141705.HKD","LU0211977185.USD","LU2097828631.EUR","FLNC","BK1610","LU1244550221.USD","LU0862451753.SGD","LU0737861772.HKD","STX","LU2293587155.HKD","LU1043141396.HKD","CDRE","BK4023","IE00BZ08YT58.USD","BK4575","IE0031619046.USD","LU2505996681.GBP","LU2487616109.SGD","LU0106261612.USD","LU0384037296.USD","BK4585","IE000BZT7R73.USD","LU1046422090.SGD","LU2023250330.USD","SGXZ86797644.SGD","LU1051768304.USD","LU1439103000.SGD","LU0061475181.USD","ORLA","LU1719994722.HKD","LU0348827113.USD","LU0444971666.USD","LU0949170772.SGD","LU0348723411.USD","LU0675040207.SGD","LU1043141123.HKD","IE00B3M56506.USD","LU2750360641.GBP","LU0417516902.SGD","BK4543","RCAT","LU0572939691.SGD","LU1051769294.HKD","LU0128525689.USD","LU0149721374.USD","LU0181495838.USD","LU0588545730.USD","LU0345770993.USD","LU0348805143.USD","BK4533","BK1584","LU1152091754.HKD","LU1506573853.SGD","BK4579","LU2476274720.SGD","LU0143863784.USD","LU2430703178.SGD","LU1282649141.HKD","LU0228659784.USD","LU1066051498.USD","LU0053666078.USD","NBIL","LU0593848301.USD","LU0329678337.USD","ASRT","HK0000107257.USD","IE0034235303.USD","LU0072913022.USD","LU0738911758.USD","LU0823039010.USD","LU0466842654.USD","LU0109394709.USD","LU1066051811.HKD","LU0819123356.HKD","LU1769817096.USD","BK4526","HK0000320264.USD","LU2357125470.USD","IE00B4R5TH58.HKD","LU1221951129.SGD","LU1642822529.SGD","BK4121","SNDK","LU0254981946.USD","LU0594300419.USD","LU0106259558.USD","REPL","LU0117841782.USD","LU0795875169.SGD","LU0545562505.USD","LU0589944569.HKD","BK4512","LU1221951046.USD","LU0797268264.HKD","BK4503","LU0477156797.USD","LU1282649810.SGD","LU1810669033.SGD","SG9999003800.SGD","LU0890818403.SGD","LU0823397103.USD","LU0306806265.USD","LU2213496289.HKD","LU0072462343.USD","LU0143863198.USD","LU0823397285.USD","IE00B5MMRT66.SGD","LU0049853897.USD","LU0499858438.USD","LU1430594728.SGD","IE00BLSP4452.SGD","LU2097828714.EUR","IE00BF5LJ272.USD","LU0820562030.AUD","BK1591","LU0502904849.HKD","LU1880383366.USD","LU2449936058.SGD","LU0608807433.USD","IE00BKVL7J92.USD","LU1732799900.SGD","LU0056508442.USD","LU0359201885.HKD","LU1032955483.USD","LU2097828805.USD","LU0396098781.USD","EOSU","LU1267930813.SGD","LU0561508036.HKD","LU0048597586.USD","LU0169518387.USD","BK4559","LU0856984785.SGD","LU1568876335.HKD","LU0054578231.USD","LU0348784397.USD","BK4139","LU0307460666.USD","LU0821914370.USD","LU1718418525.SGD","LU1794554557.SGD","LU0820561909.HKD","IE0008368304.USD","LU1242518931.SGD","LU0640798160.USD","LU1121112475.USD","SG9999001051.SGD","LU1808992512.USD","LU0831103253.SGD","LU1057294990.SGD","LU0417516738.SGD","LU1003077747.HKD","BABU","BK4122","IE00BLSP4239.USD","IE00BZ1G4Q59.USD","LU0823426480.USD","LU2242644610.SGD","NEBX","BK4587","BK1521","LU0823431563.USD","LU1282649067.USD","LU1770036033.HKD","LU0203347892.USD","BK4161","LU0070217475.USD","LU0345770308.USD","LU2097828557.USD","LU0476273544.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635467228","title":"uniQure CMO Walid Abi-Saab sells USD 1.13 million in shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2635467228","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635467228?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:55","pubTimestamp":1778619314,"startTime":"0","endTime":"0","summary":"uniQure: Chief Medical Officer Walid Abi-Saab cut ordinary share holdings to 169,669 on May 8.Disposed of 45,000 ordinary shares at prices of USD 25.1 and USD 25.Exercised stock options for 25,000 ordinary shares at USD 5.59.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. uniQure NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL7Fm6VZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"uniQure CMO Walid Abi-Saab sells USD 1.13 million in shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","QURE","LU0889565916.HKD","LU0320765992.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107759627","title":"Stock Track | uniQure NV Soars 6.87% Intraday as FDA Commissioner Announces Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=1107759627","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107759627?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:05","pubTimestamp":1778609126,"startTime":"0","endTime":"0","summary":"uniQure NV's stock surged 6.87% during Tuesday's intraday trading session, following news of a leadership change at the U.S. Food and Drug Administration.The biotech company's shares rose as FDA...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635241307","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina","url":"https://stock-news.laohu8.com/highlight/detail?id=2635241307","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635241307?lang=en_us&edition=fundamental","pubTime":"2026-05-13 01:42","pubTimestamp":1778607754,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, IlluminaWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL4N41P20U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPWR","AVEX","TYL","MAC","EBAY","REPL","FLNC","UAA","PFE","CVX","PRKS","NP","AI","ILMN","ARVN","CVS","TDIC","Q","QURE","VSTS","FANG","WEN","ZBH","HUM","XOM","ASTS","AU","VG","NVTS","APA","BZFD","IREN","PSIX","GTM","ZBRA","SNDK","ELPW","WST","ADSK","ALHC","PLUG","QCOM","INTC","RIGL","AMBQ","GME","09618","NEM","000338"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635249286","title":"BUZZ-Replimune, uniQure rise; FDA commissioner Makary plans to resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2635249286","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635249286?lang=en_us&edition=fundamental","pubTime":"2026-05-13 01:24","pubTimestamp":1778606670,"startTime":"0","endTime":"0","summary":"BUZZ-Replimune, uniQure rise; FDA commissioner Makary plans to resign** Shares of biotech firm Replimune Group REPL.O rise 14.7% to $4.2** U.S. Food and Drug Administration Commissioner Marty Makary plans to resign on Tuesday, according to two sources familiar with the situation** FDA Deputy Commissioner Kyle Diamantas will lead the agency in an acting capacity, Politico, which first reported the development, says** Last month, the health regulator declined to approve REPL's drug for the second time** U.S.-listed shares of Dutch gene therapy developer uniQure UQ1.F rise 6.1% to $29.4** FDA in March had called for a new study to support the approval of uniQure's gene therapy for the rare, inherited neurodegenerative disorder, and rejected its most recent trial for not including participants given a placebo** Shares of vaccine makers including Pfizer PFE.N and Moderna MRNA.O were up over 1%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL4N41P1ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011175.SGD","IE00B3T34201.USD","SG9999002232.USD","LU0868494617.USD","BK4592","BK4501","IE00B19Z3B42.SGD","IE0002270589.USD","SG9999003800.SGD","BK4588","LU1023059063.AUD","REPL","LU0122379950.USD","IE00BLSP4239.USD","BK4599","LU0289739699.SGD","BK4007","LU0225284248.USD","LU0456855351.SGD","BK4550","LU0234572021.USD","SG9999002224.SGD","LU1057294990.SGD","LU1066051498.USD","MRNY","LU1894683264.USD","BK4532","LU1894683348.USD","LU0225771236.USD","BK4139","BK4585","BK4568","LU0058720904.USD","BK4551","LU0306807586.USD","LU0321505439.SGD","QURE","LU0321505868.SGD","MRNX","BK4548","IE00B19Z3581.USD","SG9999001176.USD","BK4533","LU0306806265.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","SG9999013999.USD","LU0170899867.USD","LU1883839398.USD","LU0985481810.HKD","BK4534","LU1066053197.SGD","BK4581","IE00BLSP4452.SGD","SG9999001176.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633936551","title":"uniQure price target lowered to $50 from $70 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2633936551","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633936551?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:31","pubTimestamp":1778124694,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Patrick Trucchio lowered the firm’s price target on uniQure (QURE) to $50 from $70 and keeps a Buy rating on the shares aft...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/uniqure-price-target-lowered-to-50-from-70-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/uniqure-price-target-lowered-to-50-from-70-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0320765992.SGD","LU0109394709.USD","QURE","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633558741","title":"uniQure Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633558741","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633558741?lang=en_us&edition=fundamental","pubTime":"2026-05-07 02:25","pubTimestamp":1778091900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QURE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 06, 2026 14:25 ET (18:25 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","QURE","BK4139","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187509","title":"Goldman Sachs Sticks to Its Hold Rating for uniQure (QURE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187509?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:20","pubTimestamp":1778066421,"startTime":"0","endTime":"0","summary":"In a report released today, Salveen Richter from Goldman Sachs maintained a Hold rating on uniQure, with a price target of $14.00. Richter covers t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-sticks-to-its-hold-rating-for-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-sticks-to-its-hold-rating-for-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633908100","title":"Chardan Capital Remains a Buy on uniQure (QURE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633908100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633908100?lang=en_us&edition=fundamental","pubTime":"2026-05-06 12:46","pubTimestamp":1778042771,"startTime":"0","endTime":"0","summary":"Chardan Capital analyst Daniil Gataulin reiterated a Buy rating on uniQure yesterday and set a price target of $37.00. According to TipRanks, Gatau...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/chardan-capital-remains-a-buy-on-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/chardan-capital-remains-a-buy-on-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4139","LU0320765992.SGD","QURE","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633597350","title":"Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), uniQure (QURE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633597350","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633597350?lang=en_us&edition=fundamental","pubTime":"2026-05-06 06:50","pubTimestamp":1778021410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and uniQure (QURE) with bu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-spyre-therapeutics-syre-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-spyre-therapeutics-syre-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XLV","LU0109394709.USD","BK4585","LU0320765992.SGD","LU0029874061.USD","QURE","HCSG","BK4588","LU0128526141.USD","LABU","SYRE","LU0889565916.HKD","BK4581","BK4139","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633452779","title":"Uniqure NV reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633452779","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633452779?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:31","pubTimestamp":1777987905,"startTime":"0","endTime":"0","summary":"Uniqure NV reports results for the quarter ended March 31 - Earnings SummaryUniqure NV QURE.OQ reported a quarterly adjusted loss of 85 cents per share for the quarter ended March 31, lower than the s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I1TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4139","QURE","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633991765","title":"Earnings Flash (QURE) UniQure Posts Q1 Net Loss $0.85 a Share, vs. FactSet Est of $0.85 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2633991765","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633991765?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:35","pubTimestamp":1777980952,"startTime":"0","endTime":"0","summary":"Earnings Flash (QURE) UniQure Posts Q1 Net Loss $0.85 a Share, vs. FactSet Est of $0.85 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914738","title":"uniQure Q1 EPS $(0.85), Inline, Sales $3.562M Miss $5.223M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914738","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914738?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:06","pubTimestamp":1777979168,"startTime":"0","endTime":"0","summary":"uniQure (NASDAQ:QURE) reported quarterly losses of $(0.85) per share which met the analyst consensus estimate. This is a 3.66 percent decrease over losses of $(0.82) per share from the same period last year.  The company","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52276558/uniqure-q1-eps-0-85-inline-sales-3-562m-miss-5-223m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4139","LU0889565916.HKD","LU0320765992.SGD","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914703","title":"uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914703","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914703?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:05","pubTimestamp":1777979100,"startTime":"0","endTime":"0","summary":"~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~ ~ Progressing AMT-130 toward expected UK regulatory submission; MAA on track","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/05/3287519/0/en/uniQure-Announces-First-Quarter-2026-Financial-Results-and-Provides-Recent-Company-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0320765992.SGD","BK4139","BK4233","LU0889565916.HKD","UK","MAA","LU0109394709.USD","QURE","BK4215","BK4528","BK4588","BK4205"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632983456","title":"A Look At uniQure (QURE) Valuation After AMT-130 Regulatory Progress With The MHRA","url":"https://stock-news.laohu8.com/highlight/detail?id=2632983456","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632983456?lang=en_us&edition=fundamental","pubTime":"2026-05-04 02:16","pubTimestamp":1777832184,"startTime":"0","endTime":"0","summary":"Why AMT-130’s MHRA Meeting Matters for uniQure Stock\nuniQure (QURE) has moved a step further along the regulatory path for AMT-130 in Huntington’s disease after a Pre-Submission Meeting with the UK’s Medicines and Healthcare products Regulatory Agency.\nThe company now plans to file a Marketing Authorization Application in the third quarter of 2026, using three year Phase I/II data that reported a 75% slowing of disease progression at the high dose, with a generally well tolerated and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/a-look-at-uniqure-qure-valuation-after-amt-130-regulatory-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/a-look-at-uniqure-qure-valuation-after-amt-130-regulatory-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4534","LU0109394709.USD","AMT","BK4084","BK4219","BK4554","BK4585","BK4581","LU2065732104.USD","BK4139","LU0889565916.HKD","BK4097","PRGS","QURE","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632769807","title":"uniQure Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2632769807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632769807?lang=en_us&edition=fundamental","pubTime":"2026-05-01 07:53","pubTimestamp":1777593180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QURE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2026 19:53 ET (23:53 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4139","QURE","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632481667","title":"uniQure price target raised to $37 from $31 at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2632481667","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632481667?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:15","pubTimestamp":1777587349,"startTime":"0","endTime":"0","summary":"Chardan raised the firm’s price target on uniQure (QURE) to $37 from $31 and keeps a Buy rating on the shares. The firm cites the company announcem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/uniqure-price-target-raised-to-37-from-31-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/uniqure-price-target-raised-to-37-from-31-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QURE","LU0889565916.HKD","BK4139","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.uniqure.com","stockEarnings":[{"period":"1week","weight":0.0186},{"period":"1month","weight":0.3949},{"period":"3month","weight":0.0113},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.659},{"period":"ytd","weight":0.051}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0513},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1043},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.009035},{"month":2,"riseRate":0.5,"avgChangeRate":0.032875},{"month":3,"riseRate":0.307692,"avgChangeRate":-0.046417},{"month":4,"riseRate":0.461538,"avgChangeRate":0.033828},{"month":5,"riseRate":0.692308,"avgChangeRate":0.05971},{"month":6,"riseRate":0.416667,"avgChangeRate":-0.009437},{"month":7,"riseRate":0.25,"avgChangeRate":0.033059},{"month":8,"riseRate":0.5,"avgChangeRate":0.005984},{"month":9,"riseRate":0.25,"avgChangeRate":0.122705},{"month":10,"riseRate":0.5,"avgChangeRate":0.060394},{"month":11,"riseRate":0.75,"avgChangeRate":0.0616},{"month":12,"riseRate":0.25,"avgChangeRate":0.125134}],"exchange":"NASDAQ","name":"uniQure NV","nameEN":"uniQure NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest uniQure NV(QURE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"uniQure NV,QURE,uniQure NV股票,uniQure NV股票老虎,uniQure NV股票老虎国际,uniQure NV行情,uniQure NV股票行情,uniQure NV股价,uniQure NV股市,uniQure NV股票价格,uniQure NV股票交易,uniQure NV股票购买,uniQure NV股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest uniQure NV(QURE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}